Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy R1 RCM stock | $22.76

Learn how to easily invest in R1 RCM stock.

R1 RCM Inc is a health information services business based in the US. R1 RCM shares (RCM) are listed on the NASDAQ and all prices are listed in US Dollars. R1 RCM employs 19,000 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in R1 RCM

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RCM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

R1 RCM stock price (NASDAQ: RCM)

Use our graph to track the performance of RCM stocks over time.

R1 RCM shares at a glance

Information last updated 2021-10-16.
Latest market close$22.76
52-week range$16.62 - $31.28
50-day moving average $21.31
200-day moving average $22.46
Wall St. target price$31.16
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.76

Buy R1 RCM shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy R1 RCM stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

R1 RCM price performance over time

Historical closes compared with the close of $22.76 from 2021-10-21

1 week (2021-10-15) 1.11%
1 month (2021-09-22) 5.37%
3 months (2021-07-22) 10.38%
6 months (2021-04-22) -12.90%
1 year (2020-10-22) 30.88%
2 years (2019-10-22) 122.27%
3 years (2018-10-22) 161.61%
5 years (2016-10-21) 860.34%

Is R1 RCM under- or over-valued?

Valuing R1 RCM stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of R1 RCM's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

R1 RCM's PEG ratio

R1 RCM's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.403. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into R1 RCM's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

R1 RCM's EBITDA

R1 RCM's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $214 million.

The EBITDA is a measure of a R1 RCM's overall financial performance and is widely used to measure a its profitability.

R1 RCM financials

Revenue TTM $1.3 billion
Operating margin TTM 10.77%
Gross profit TTM $249.7 million
Return on assets TTM 7.73%
Return on equity TTM 42.08%
Profit margin 9.61%
Book value $1.16
Market capitalisation $6.3 billion

TTM: trailing 12 months

Shorting R1 RCM shares

There are currently 4.9 million R1 RCM shares held short by investors – that's known as R1 RCM's "short interest". This figure is 0.3% down from 4.9 million last month.

There are a few different ways that this level of interest in shorting R1 RCM shares can be evaluated.

R1 RCM's "short interest ratio" (SIR)

R1 RCM's "short interest ratio" (SIR) is the quantity of R1 RCM shares currently shorted divided by the average quantity of R1 RCM shares traded daily (recently around 1.1 million). R1 RCM's SIR currently stands at 4.39. In other words for every 100,000 R1 RCM shares traded daily on the market, roughly 4390 shares are currently held short.

However R1 RCM's short interest can also be evaluated against the total number of R1 RCM shares, or, against the total number of tradable R1 RCM shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case R1 RCM's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 R1 RCM shares in existence, roughly 20 shares are currently held short) or 0.0358% of the tradable shares (for every 100,000 tradable R1 RCM shares, roughly 36 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against R1 RCM.

Find out more about how you can short R1 RCM stock.

R1 RCM share dividends

We're not expecting R1 RCM to pay a dividend over the next 12 months.

R1 RCM share price volatility

Over the last 12 months, R1 RCM's shares have ranged in value from as little as $16.62 up to $31.28. A popular way to gauge a stock's volatility is its "beta".

RCM.US volatility(beta: 0.76)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while R1 RCM's is 0.7619. This would suggest that R1 RCM's shares are less volatile than average (for this exchange).

R1 RCM overview

R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers. It also provides modular services comprising physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. It serves healthcare providers, including health systems, hospitals, and physician groups. The company was formerly known as Accretive Health, Inc.

Frequently asked questions

What percentage of R1 RCM is owned by insiders or institutions?
Currently 1.253% of R1 RCM shares are held by insiders and 93.256% by institutions.
How many people work for R1 RCM?
Latest data suggests 19,000 work at R1 RCM.
When does the fiscal year end for R1 RCM?
R1 RCM's fiscal year ends in December.
Where is R1 RCM based?
R1 RCM's address is: 401 North Michigan Avenue, Chicago, IL, United States, 60611
What is R1 RCM's ISIN number?
R1 RCM's international securities identification number is: US7493971052
What is R1 RCM's CUSIP number?
R1 RCM's Committee on Uniform Securities Identification Procedures number is: 00438V103

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site